NasdaqGM - Nasdaq Real Time Price • USD
LifeMD, Inc. (LFMD)
At close: April 25 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
152,547.01
152,547.01
119,033.52
92,875.81
37,293.91
Cost of Revenue
18,900.46
18,900.46
18,668.03
17,995.39
8,861.19
Gross Profit
133,646.54
133,646.54
100,365.49
74,880.41
28,432.72
Operating Expense
148,135.82
148,135.82
140,051.68
129,181.49
86,252.18
Operating Income
-14,489.27
-14,489.27
-39,686.19
-54,301.08
-57,819.45
Net Non Operating Interest Income Expense
-2,596.59
-2,596.59
-1,275.95
-3,019.72
-1,667.54
Other Income Expense
-325.20
-325.20
-3,698.20
-3,995.56
-914.86
Pretax Income
-17,411.06
-17,411.06
-44,660.33
-61,316.36
-60,401.85
Tax Provision
428.00
428.00
360.70
7.70
122.50
Net Income Common Stockholders
-23,702.24
-23,702.24
-48,641.91
-61,769.18
-63,362.96
Diluted NI Available to Com Stockholders
-23,702.24
-23,702.24
-48,641.91
-61,769.18
-63,362.96
Basic EPS
-0.70
--
-1.57
-2.29
-4.44
Diluted EPS
-0.70
--
-1.57
-2.29
-4.44
Basic Average Shares
33,905.16
--
30,976.46
27,007.96
14,275.15
Diluted Average Shares
33,905.16
--
30,976.46
27,007.96
14,275.15
Total Operating Income as Reported
-14,489.27
-14,489.27
-43,447.78
-54,301.08
-57,819.45
Total Expenses
167,036.28
167,036.28
158,719.71
147,176.89
95,113.36
Net Income from Continuing & Discontinued Operation
-20,595.99
-20,595.99
-45,535.66
-60,897.70
-58,646.94
Normalized Income
-20,339.09
-20,339.09
-42,614.08
-57,980.95
-57,979.09
Net Interest Income
-2,596.59
-2,596.59
-1,275.95
-3,019.72
-1,667.54
EBIT
-14,489.27
-14,489.27
-39,686.19
-54,301.08
-57,819.45
EBITDA
-7,889.05
-7,889.05
-35,915.95
-53,432.32
-57,421.69
Reconciled Cost of Revenue
18,900.46
18,900.46
18,668.03
17,995.39
8,861.19
Reconciled Depreciation
6,600.23
6,600.23
3,770.23
868.76
397.77
Net Income from Continuing Operation Net Minority Interest
-20,595.99
-20,595.99
-45,535.66
-60,897.70
-58,646.94
Total Unusual Items Excluding Goodwill
-325.20
-325.20
-3,698.20
-3,995.56
-914.86
Total Unusual Items
-325.20
-325.20
-3,698.20
-3,995.56
-914.86
Normalized EBITDA
-7,563.85
-7,563.85
-32,217.76
-49,436.77
-56,506.83
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-68.29
-68.29
-776.62
-1,078.80
-247.01
12/31/2020 - 1/29/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OTRK Ontrak, Inc.
0.3330
-0.69%
TALK Talkspace, Inc.
3.0800
+0.33%
EVH Evolent Health, Inc.
28.32
-3.21%
PGNY Progyny, Inc.
32.50
-0.31%
HQY HealthEquity, Inc.
79.04
-0.20%
OPRX OptimizeRx Corporation
8.80
-3.93%
AUGX Augmedix, Inc.
2.7900
-2.11%
SPOK Spok Holdings, Inc.
15.44
-0.71%
TALKW Talkspace, Inc.
0.2100
0.00%
MDRM Modern Mobility Aids, Inc.
0.0110
0.00%